Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement

Ned Calonge; Diana B. Petitti; Thomas G. DeWitt; Leon Gordis; Allen J. Dietrich; Kimberly D. Gregory; Russell Harris; George J. Isham; Michael L. LeFevre; Roseanne Leipzig; Carol Loveland-Cherry; Lucy N. Marion; Virginia A. Moyer; Judith K. Ockene; George F. Sawaya; Barbara P. Yawn

doi:10.7326/0003-4819-148-7-200804010-00212

Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Allen J. Dietrich, Kimberly D. Gregory, Russell Harris, George J. Isham, Michael L. LeFevre, Roseanne Leipzig, Carol Loveland-Cherry, Lucy N. Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Barbara P. Yawn

Biobehavioral Nursing

Research output: Contribution to journal › Review article › peer-review

111 Scopus citations

Abstract

Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

Original language	English (US)
Pages (from-to)	529-534
Number of pages	6
Journal	Annals of internal medicine
Volume	148
Issue number	7
DOIs	https://doi.org/10.7326/0003-4819-148-7-200804010-00212
State	Published - Apr 1 2008

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-148-7-200804010-00212

Cite this

Calonge, N., Petitti, D. B., DeWitt, T. G., Gordis, L., Dietrich, A. J., Gregory, K. D., Harris, R., Isham, G. J., LeFevre, M. L., Leipzig, R., Loveland-Cherry, C., Marion, L. N., Moyer, V. A., Ockene, J. K., Sawaya, G. F., & Yawn, B. P. (2008). Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement. Annals of internal medicine, 148(7), 529-534. https://doi.org/10.7326/0003-4819-148-7-200804010-00212

Calonge, N, Petitti, DB, DeWitt, TG, Gordis, L, Dietrich, AJ, Gregory, KD, Harris, R, Isham, GJ, LeFevre, ML, Leipzig, R, Loveland-Cherry, C, Marion, LN, Moyer, VA, Ockene, JK, Sawaya, GF & Yawn, BP 2008, 'Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement', Annals of internal medicine, vol. 148, no. 7, pp. 529-534. https://doi.org/10.7326/0003-4819-148-7-200804010-00212

@article{b14c9c13632f4c9e9095afd0ca496096,

title = "Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement",

abstract = "Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).",

author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Leon Gordis and Dietrich, {Allen J.} and Gregory, {Kimberly D.} and Russell Harris and Isham, {George J.} and LeFevre, {Michael L.} and Roseanne Leipzig and Carol Loveland-Cherry and Marion, {Lucy N.} and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Yawn, {Barbara P.}",

year = "2008",

month = apr,

day = "1",

doi = "10.7326/0003-4819-148-7-200804010-00212",

language = "English (US)",

volume = "148",

pages = "529--534",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "7",

}

TY - JOUR

T1 - Screening for chronic obstructive pulmonary disease using spirometry

T2 - U.S. preventive services task force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Gordis, Leon

AU - Dietrich, Allen J.

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Isham, George J.

AU - LeFevre, Michael L.

AU - Leipzig, Roseanne

AU - Loveland-Cherry, Carol

AU - Marion, Lucy N.

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Yawn, Barbara P.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

AB - Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

UR - http://www.scopus.com/inward/record.url?scp=42249091193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249091193&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-148-7-200804010-00212

DO - 10.7326/0003-4819-148-7-200804010-00212

M3 - Review article

C2 - 18316747

AN - SCOPUS:42249091193

SN - 0003-4819

VL - 148

SP - 529

EP - 534

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 7

ER -

Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this